Study Finds No Statistical Link Between E-Cigarette Use and Smoking Among Youth

Oct.21.2022
Study Finds No Statistical Link Between E-Cigarette Use and Smoking Among Youth
A recent study found no statistical association between e-cigarette use and regular smoking in participants aged 16 to 24.

Many anti-e-cigarette advocates believe that e-cigarettes may serve as a gateway to smoking. A study titled "Smoking Intentions and Progression from e-Cigarette Use to Smoking" claims that the use of e-cigarettes among adolescents who had no prior intention to smoke is associated with an increased risk of future smoking.


Currently, research is being conducted to measure the gateway effect by examining the relationship between electronic cigarette use and overall smoking rates among young people, including non-smokers. If there is indeed a gateway effect, then the change in smoking rates among those who are associated with smoking should increase in tandem with the use of electronic cigarettes. However, the authors of the study found no statistically significant correlation between the use of electronic cigarettes and regular smoking among participants aged 16 to 24.


These research findings indicate that we can rule out the previously reported large gateway effect, especially in the 18 to 24 age group. However, we cannot rule out smaller gateway effects, and we have not studied younger age groups. If the estimates are correct, we estimate that around 7,000 out of 74,000 16 to 17-year-old e-cigarette users in England will become regular cigarette smokers due to e-cigarette use. At the same time, an estimated 50,000 smokers quit smoking each year due to e-cigarette use," said lead researcher Dr. Emma Beard.


In countries and regions where e-cigarettes are recognized, there is no evidence that they are creating a gateway effect.


According to the findings of these investigations, countries such as the UK and New Zealand, which support the use of e-cigarettes as a means of quitting smoking, not only report low smoking rates, but also do not have an increased proportion of teenagers using e-cigarettes. Reports from these countries are consistent with previous studies on these patterns, and a recent article titled "Does the Gateway Theory Justify the Prohibition of Nicotine E-Cigarettes in Australia?" has once again refuted the gateway theory.


Comment authors Colin Mendelsohn and Wayne Hall point out that a more reasonable explanation as to why young people who vape are more likely to smoke is attributed to personality factors. This means that teenagers who vape are more likely to be risk-takers, and therefore more prone to smoking, drinking alcohol, using cannabis and other substances, as well as engaging in unprotected sex. This argument has been emphasized by other experts in several studies.


The major findings reviewed by Mendelsohn and Hall are as follows:


Smoking usually precedes the use of electronic cigarettes. At least 70-85% of teenage smokers try using electronic cigarettes after starting to smoke. Most teenage electronic cigarette users are experimental and regular use of electronic cigarettes among non-smokers is rare. In Australia and international surveys, the proportion of non-smokers who regularly use electronic cigarettes is usually 1% or less. Many teenage electronic cigarette users only use flavorings and do not use nicotine. Nicotine addiction is rare among electronic cigarette users who do not smoke. In the United States, less than 4% of non-smoking youth who use electronic cigarettes have symptoms of nicotine dependence. Some teenagers use electronic cigarettes to quit smoking. Since the introduction of electronic cigarettes, teenage smoking rates have declined rapidly in the United Kingdom and the United States, making it unlikely that electronic cigarettes will increase teenage smoking. Electronic cigarettes are more likely to steer some high-risk teenagers away from smoking and towards safer alternatives.


Statement:


This article is compiled based on third-party information and is intended for industry professionals to exchange and learn from.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The compilation of this article is only intended for communication and research within the industry.


Due to limitations in translation ability, the translated article may not fully express the same meaning as the original text. Therefore, please refer to the original text for accuracy.


Regarding any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions, 2FIRSTS fully aligns with the Chinese government.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
British American Tobacco Japan (BAT Japan) expanded VELO Peach Ice Medium to FamilyMart stores nationwide in Japan from September 7, 2026. The oral tobacco product first launched on July 6 and had previously been sold through VELO's official online store, glo Store Ginza and tobacco retailers. It combines peach flavor with menthol cooling at a Medium strength level and is priced at JPY 360. Japanese tobacco retailers list 15 pouches per pack. The move adds the new SKU to an existing nationwide FamilyMart distribution network for VELO rather than marking the brand's first entry into the convenience-store chain.
Sep.15
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's liquid-vape market is showing changes across raw-material imports, product types and sales channels after synthetic nicotine came under the Tobacco Business Act on April 24. Customs data show nicotine-analogue imports totaled 12,126 kilograms from April through August, while synthetic-nicotine imports over the same five months totaled 231,663 kilograms, just 39.3% of the amount imported in March alone. Physical liquid-vape stores tracked in Seoul and Gyeonggi Province fell 9.9%, unmanned outlets edged higher and online sales listings increased from 27,774 to 42,437. Government testing of 105 liquid inhalation products promoted as nicotine-free separately found nicotine in 13 and 6-methylnicotine in 12.
Sep.22
Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Japan Tobacco International (JTI) has introduced PERLZ nicotine pearls in the UK, expanding its oral nicotine portfolio beyond conventional nicotine pouches. The fully dissolvable, multi-layer pearls are placed under the tongue and come in Mint and Berry flavors at concentrations of 1mg/g and 2mg/g, equivalent to approximately 0.3mg and 0.5mg of nicotine per pearl. UK retailer Haypp published four 30-pearl dispenser listings on July 31, 2026, followed by three 10-pearl sachet products on August 17. The dispensers retail for £6.50, while the sachets cost £2.50.
product
Oct.12
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
At InterTabac 2026 in Dortmund, PMI is presenting multiple brands and products along “The PMI Boulevard,” including IQOS, ZYN, VEEV and Marlboro. On-site images captured by 2Firsts show dedicated spaces including the IQOS Boutique, ZYN Café, PMI Gallery and Marlboro Office
Market
Sep.16 by 2Firsts Perspectives
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Four CrossBar 20K disposable e-cigarettes appeared on Pennsylvania's 163-entry ENDS directory ahead of enforcement beginning October 19, 2026. The devices feature 13mL e-liquid reservoirs, 50mg/mL nicotine, 2,000mAh batteries and 0.9Ω mesh coils, with advertised puff counts of up to 20,000. CrossBar was the only modern high-puff disposable series among the directory's 15 disposable entries. Its packaging emphasizes New York design and Japanese-origin flavoring, while historical CrossBar records identify a registered U.S. tobacco manufacturing-related establishment. The link between the newer 13mL devices and earlier 1.3mL PMTA filings remains unconfirmed.
product
Oct.26